Prof Siow Ming Lee is Professor of Medical Oncology and Consultant Medical Oncologist at University College London Hospital (UCLH). He is an internationally recognised authority on lung cancer treatment and research. He has led several National Cancer Research Institute (NCRI) lung cancer trials over the past three decades in the UK, which have changed clinical practice and improved treatment outcomes for lung cancer patients.

Professor Lee is the Clinical Lead for the UCLH Thoracic Medical Oncology Unit and chairs the London Lung Cancer Group, which has an international research reputation. He previously was chairperson for the NCRI Lung Cancer Advanced Disease Subgroup, NCRI Brain New-agents Clinical Subgroup, and committee member of CTACC, NCRI Lung, NCRI Brain, and NCRI Lymphoma Groups.

His team was also part of the international FLAURA and KEYNOTE-189 Investigators. His trials have been recognised at major international conferences with many invited Presidential, Plenary, and Oral Presentations at World Lung Cancer Conference, ASCO, and ESMO, and resulted in several 1st or senior author publications in high-impact journals. His practice-changing trials and 4* high-impact research publications were used for the REF 2014 exercise which ranked UCL top for research in the UK.